EBV gene expression in an NPC-related tumour - PubMed (original) (raw)
EBV gene expression in an NPC-related tumour
M M Hitt et al. EMBO J. 1989 Sep.
Abstract
A nasopharyngeal carcinoma tumour (designated C15) propagated in nude mice has been used to generate a large cDNA library that we have analysed for Epstein-Barr virus (EBV) gene expression. No gross alterations exist in viral DNA from C15 relative to other human isolates and the large deletion present in the B95-8 'prototype' viral strain established in marmoset cells is not found; C15 contains no linear virion DNA. In the cDNA library, of the six EBV nuclear antigens (EBNAs) expressed in latently infected B-lymphocytes, only clones for EBNA-1 are found. These data are confirmed by immunoblotting. Sequence analysis shows the EBNA-1 mRNA splicing pattern in the carcinoma to differ from that observed in B-lymphocytes. Further, contrary to observations with B-cell lines, most viral transcription in the tumour is localized onto the 'rightmost' region of the conventional EBV physical map. Transcripts identified corresponding to known genes include those for the latent membrane protein (LMP), the alkaline DNA exonuclease and probably the terminal protein; major transcripts are also derived from the BamHI D fragment and the region deleted in B95-8 EBV DNA. Novel transcripts have also been identified that proceed in an anti-sense direction to genes encoding functions associated with replication, such as the viral DNA polymerase. They contain a large, hitherto unidentified, open reading frame in the viral genome that is complementary to the putative function known as BALF3 and a smaller open reading frame complementary to BALF5 (the DNA polymerase gene). From the present studies we can conclude that: (i) EBV transcription patterns in the epithelial cells vary markedly from those identified previously in B-cells, reflecting differential use of promoters or splicing patterns. (ii) Transcription is tightly regulated and restricted in the C15 tumour with many latent genes, notably EBNAs 2-6, being 'switched off.' (iii) A family of cytoplasmic RNAs are transcribed in an antisense direction to a number of existing open reading frames in the EBV genome. (iv) There are a number of mutations in C15 transcripts relative to the B95-8 genome, some of which could result in amino acid alterations in proteins.
Similar articles
- Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma.
Gilligan K, Sato H, Rajadurai P, Busson P, Young L, Rickinson A, Tursz T, Raab-Traub N. Gilligan K, et al. J Virol. 1990 Oct;64(10):4948-56. doi: 10.1128/JVI.64.10.4948-4956.1990. J Virol. 1990. PMID: 2168978 Free PMC article. - Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells.
Smith PR, Griffin BE. Smith PR, et al. J Virol. 1992 Feb;66(2):706-14. doi: 10.1128/JVI.66.2.706-714.1992. J Virol. 1992. PMID: 1370554 Free PMC article. - Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.
Hu LF, Minarovits J, Cao SL, Contreras-Salazar B, Rymo L, Falk K, Klein G, Ernberg I. Hu LF, et al. J Virol. 1991 Mar;65(3):1558-67. doi: 10.1128/JVI.65.3.1558-1567.1991. J Virol. 1991. PMID: 1847471 Free PMC article. - Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors.
Smith PR, Gao Y, Karran L, Jones MD, Snudden D, Griffin BE. Smith PR, et al. J Virol. 1993 Jun;67(6):3217-25. doi: 10.1128/JVI.67.6.3217-3225.1993. J Virol. 1993. PMID: 8098777 Free PMC article. - Immortalizing genes of Epstein-Barr virus.
Middleton T, Gahn TA, Martin JM, Sugden B. Middleton T, et al. Adv Virus Res. 1991;40:19-55. doi: 10.1016/s0065-3527(08)60276-6. Adv Virus Res. 1991. PMID: 1659776 Review.
Cited by
- Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis.
Ruf IK, Rhyne PW, Yang C, Cleveland JL, Sample JT. Ruf IK, et al. J Virol. 2000 Nov;74(21):10223-8. doi: 10.1128/jvi.74.21.10223-10228.2000. J Virol. 2000. PMID: 11024153 Free PMC article. - Epstein-Barr Virus BART Long Non-coding RNAs Function as Epigenetic Modulators in Nasopharyngeal Carcinoma.
Verhoeven RJA, Tong S, Mok BW, Liu J, He S, Zong J, Chen Y, Tsao SW, Lung ML, Chen H. Verhoeven RJA, et al. Front Oncol. 2019 Oct 22;9:1120. doi: 10.3389/fonc.2019.01120. eCollection 2019. Front Oncol. 2019. PMID: 31696060 Free PMC article. - Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
Tierney RJ, Steven N, Young LS, Rickinson AB. Tierney RJ, et al. J Virol. 1994 Nov;68(11):7374-85. doi: 10.1128/JVI.68.11.7374-7385.1994. J Virol. 1994. PMID: 7933121 Free PMC article. - Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.
Fries KL, Miller WE, Raab-Traub N. Fries KL, et al. J Virol. 1996 Dec;70(12):8653-9. doi: 10.1128/JVI.70.12.8653-8659.1996. J Virol. 1996. PMID: 8970991 Free PMC article. - Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.
Miller WE, Mosialos G, Kieff E, Raab-Traub N. Miller WE, et al. J Virol. 1997 Jan;71(1):586-94. doi: 10.1128/JVI.71.1.586-594.1997. J Virol. 1997. PMID: 8985387 Free PMC article.
References
- J Virol. 1984 Aug;51(2):411-9 - PubMed
- J Med Virol. 1989 Apr;27(4):269-73 - PubMed
- Proc Natl Acad Sci U S A. 1984 Aug;81(15):4930-4 - PubMed
- EMBO J. 1984 Aug;3(8):1913-7 - PubMed
- Mol Biol Med. 1983 Jul;1(1):21-45 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources